Acumen Pharmaceuticals, Inc. ABOS
ABOS
Acumen Pharmaceuticals, Inc. ALXO
ALX Oncology Holdings Inc. ZNTL
Zentalis Pharmaceuticals, Inc. ADVM
Adverum Biotechnologies, Inc. GUTS
Fractyl Health, Inc. Common Stock IMDX
Insight Molecular Diagnostics Inc. INO
Inovio Pharmaceuticals, Inc. IRD
Opus Genetics, Inc. AGEN
Agenus Inc. IMUX
Immunic, Inc.
Acumen Pharmaceuticals, Inc. ALXO
ALX Oncology Holdings Inc. ZNTL
Zentalis Pharmaceuticals, Inc. ADVM
Adverum Biotechnologies, Inc. GUTS
Fractyl Health, Inc. Common Stock IMDX
Insight Molecular Diagnostics Inc. INO
Inovio Pharmaceuticals, Inc. IRD
Opus Genetics, Inc. AGEN
Agenus Inc. IMUX
Immunic, Inc.
Performance
| Periode | ABOS | ALXO | ZNTL | ADVM | GUTS | IMDX | INO | IRD | AGEN | IMUX |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 92.79 % | 234.69 % | 36.59 % | 40.23 % | 32.67 % | 39.93 % | 59.63 % | 176.64 % | 133.53 % | -0.19 % |
| YTD | 15.68 % | 5.13 % | -44.00 % | 0.21 % | -37.09 % | 66.95 % | 41.21 % | 55.56 % | 28.48 % | -11.91 % |
| 1Y | -8.94 % | 5.81 % | -43.24 % | -37.77 % | -44.63 % | 24.68 % | -54.91 % | 56.80 % | -16.07 % | -38.46 % |
| 3Y | -73.71 % | -85.61 % | -92.73 % | -47.14 % | -89.57 % | -75.06 % | -87.40 % | 51.94 % | -92.31 % | -91.68 % |
| 5Y | -89.35 % | -95.47 % | -95.89 % | -95.89 % | -89.57 % | -86.68 % | -98.33 % | 51.94 % | -95.58 % | -95.34 % |
| 10Y | -89.35 % | -94.53 % | -92.76 % | -93.85 % | -89.57 % | -97.59 % | -96.21 % | 51.94 % | -95.64 % | -99.56 % |
| From the beginning | -89.35 % | -94.53 % | -92.76 % | -98.28 % | -89.57 % | -97.59 % | -99.64 % | 51.94 % | -99.95 % | -99.81 % |